Cargando…
p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse
Autism spectrum disorder (ASD) is a common neurobehavioral disorder with limited treatment options. Activation of p38 MAPK signaling networks has been identified in ASD, and p38 MAPK signaling elevates serotonin (5-HT) transporter (SERT) activity, effects mimicked by multiple, hyperfunctional SERT c...
Autores principales: | Robson, Matthew J., Quinlan, Meagan A., Margolis, Kara Gross, Gajewski-Kurdziel, Paula A., Veenstra-VanderWeele, Jeremy, Gershon, Michael D., Watterson, D. Martin, Blakely, Randy D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205438/ https://www.ncbi.nlm.nih.gov/pubmed/30297392 http://dx.doi.org/10.1073/pnas.1809137115 |
Ejemplares similares
-
Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant
por: Quinlan, Meagan A., et al.
Publicado: (2020) -
Rare Opportunities for Insights Into Serotonergic Contributions to Brain and Bowel Disorders: Studies of the SERT Ala56 Mouse
por: Stilley, Samantha E., et al.
Publicado: (2021) -
Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice
por: Kerr, Travis M, et al.
Publicado: (2013) -
Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse
por: Veenstra-VanderWeele, Jeremy, et al.
Publicado: (2009) -
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
por: Morotti, Matteo, et al.
Publicado: (2019)